Literature DB >> 1972765

Clinical and immunological studies on patients with Graves' disease preoperatively treated with corticosteroids and iodides.

Y Kasuga1, A Sugenoya, S Kobayashi, G Kaneko, H Masuda, M Fujimori, S Takahashi, F Iida.   

Abstract

The purpose of this study was to evaluate the acute effects of corticosteroid and iodide preoperative therapy in patients with Graves' disease in terms of thyroid function and immunological parameters. The above combination was prescribed for 4 patients who had experienced severe side effects from antithyroid drugs (ATD) in order to reduce the possibility of post-thyroidectomy thyroid storm. Corticosteroids were employed daily for four days, and iodides were given daily for two weeks prior to thyroidectomy. The free T3 values decreased rapidly to euthyroid levels following the administration of both drugs, although the free T4 values were still much higher than normal in 3 of the 4 patients at the time of surgery. By comparison, 3 of 8 patients treated with ATD also had thyroid hormone levels above normal. Studies of lymphocyte subsets revealed that the percentage of helper T cells was significantly less in the corticosteroid-iodide treatment group than in the control and ATD groups. It is thus possible that postoperative thyroid storm might be prevented through corticosteroid-iodide therapy by virtue of the reduction of free T3 values to within the normal range by the time of surgery. The acute suppression of helper T cells was another results of this form of therapy observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1972765     DOI: 10.1007/bf02470662

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  23 in total

1.  GLUCOCORTICOID-INDUCED DISAPPEARANCE OF LONG-ACTING THYROID STIMULATOR IN THE OPHTHALMOPATHY OF GRAVES' DISEASE.

Authors:  N J SNYDER; D E GREEN; D H SOLOMON
Journal:  J Clin Endocrinol Metab       Date:  1964-11       Impact factor: 5.958

2.  Immunoregulation in autoimmune thyroid disease.

Authors:  R Volpé
Journal:  N Engl J Med       Date:  1987-01-01       Impact factor: 91.245

3.  Immunological studies of autoimmune thyroid disorders: abnormalities in the inducer T cell subset and proliferative responses to autologous and allogeneic stimulation.

Authors:  C Fournier; H Chen; A Leger; J Charreire
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

4.  Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study.

Authors:  C S Teng; R T Yeung
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

5.  Rapid improvement of thyroid function by using glucocorticoid indicated for the preoperative preparation of subtotal thyroidectomy in Graves' disease.

Authors:  Y Ozawa; H Daida; T Shimizu; Y Shishiba
Journal:  Endocrinol Jpn       Date:  1983-02

6.  Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3).

Authors:  I J Chopra; D E Williams; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-11       Impact factor: 5.958

7.  Analysis of T cell subsets in Graves' disease: alterations associated with carbimazole.

Authors:  M E Ludgate; A M McGregor; A P Weetman; S Ratanachaiyavong; J H Lazarus; R Hall; G W Middleton
Journal:  Br Med J (Clin Res Ed)       Date:  1984-02-18

8.  Acute effects of corticosteroids on thyroid activity in Graves' disease.

Authors:  D E Williams; I J Chopra; J Orgiazzi; D H Solomon
Journal:  J Clin Endocrinol Metab       Date:  1975-08       Impact factor: 5.958

9.  A receptor assay for the measurement of TSH receptor antibodies in unextracted serum.

Authors:  K Southgate; F Creagh; M Teece; C Kingswood; B Rees Smith
Journal:  Clin Endocrinol (Oxf)       Date:  1984-05       Impact factor: 3.478

10.  Methimazole inhibits thyroid autoantibody production by an action on accessory cells.

Authors:  A P Weetman; A M McGregor; R Hall
Journal:  Clin Immunol Immunopathol       Date:  1983-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.